s
Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG
09-12-2024, 10:45
FRANKFURT, Germany, Dec. 9, 2024 /PRNewswire/ — Zentiva AG, a wholly-owned subsidiary of Zentiva Pharma GmbH, headquartered in Frankfurt am Main, Germany, and part of Zentiva group (“Zentiva”), completed the voluntary public purchase offer for the shares of APONTIS PHARMA AG (“APONTIS PHARMA”). Zentiva now holds approx. 83.57% of the share capital and approx. 85.27% […] L'articolo Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG proviene da La Ragione.
CONTINUA A LEGGERE
23
0
0
Guarda anche
Libero Quotidiano
Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG
Libero Quotidiano
One Rock Capital Partners Completes Acquisition of Europe Snacks
La Ragione
09:43
Innovazione ed export punti di forza del florovivaismo
La Ragione
07:49